The evidence base for hydrolysed collagen peptides
Hydrolysed collagen consists of low-molecular-weight peptide fragments derived from native collagen via enzymatic hydrolysis. While native collagen is abundant in animal connective tissues and bone broth, the hydrolysed peptide form is specifically engineered for high intestinal permeability and bioavailability. This research corpus examines its mechanisms of action in stimulating dermal fibroblasts, modulating matrix metalloproteinases, and supporting articular cartilage and bone tissue integrity.
Evidence at a glance
Bioavailability
Identification of food-derived collagen peptides in human blood after oral ingestion of gelatin hydrolysates
Small-sample open-label human bioavailability study without a placebo control — mechanistic, not efficacy.
Tier 3Comparison of quantity and structures of hydroxyproline-containing peptides in human blood after oral ingestion of gelatin hydrolysates from different sources
Very small single-blind human crossover comparing peptide profiles across three collagen sources — mechanistic, hypothesis-generating for source-specific effects.
Tier 3Oral ingestion of collagen hydrolysate leads to the transportation of highly concentrated Gly-Pro-Hyp and its hydrolyzed form of Pro-Hyp into the bloodstream and skin
Small human single-blind crossover for plasma kinetics plus supportive murine tissue-distribution arm — mechanistic, industry-authored on a proprietary product.
Tier 4Assessment of bioavailability after in vitro digestion and first pass metabolism of bioactive peptides from collagen hydrolysates
In vitro simulated gastrointestinal digestion + Caco-2/HepG2 transwell co-culture model — mechanistic in vitro study, no human data. Bridges the peptide-identification human studies (Iwai, Ohara, Yazaki) to first-pass hepatic metabolism which those studies did not address.
Tier 4Bone broth unlikely to provide reliable concentrations of collagen precursors compared to supplemental sources of collagen used in collagen research
Analytical laboratory study measuring amino acid content of bone broth vs commercial collagen supplements — comparative composition analysis, not a clinical outcome study.
Biology and biochemistry
Bone
A calcium-collagen chelate dietary supplement attenuates bone loss in postmenopausal women with osteopenia: a randomized controlled trial
12-month randomised controlled trial with DXA-verified BMD endpoints in postmenopausal osteopenic women — solid design but small sample (n = 39) and industry-funded/supplied.
Tier 4Assessment of effectiveness of oral administration of collagen peptide on bone metabolism in growing and mature rats
Animal (rat) dose-ranging safety and efficacy study with high-dose kidney histology — foundational safety citation reference. Preclinical, no human data.
Joint
24-Week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint pain
Multi-site double-blind placebo-controlled RCT with 24-week follow-up in college athletes, primary endpoint pain reduction — solid RCT design but industry-sponsored (GELITA) and modest sample retention.
Tier 2A randomized controlled trial on the efficacy and safety of a food ingredient, collagen hydrolysate, for improving joint comfort
Multicentre double-blind placebo-controlled 6-month RCT with n=250 in diagnosed knee OA — one of the largest and longest collagen-for-OA trials, though industry involvement present.
Tier 1Collagen hydrolysate for the treatment of osteoarthritis and other joint disorders: a review of the literature
Comprehensive narrative review synthesising preclinical and clinical evidence for collagen hydrolysate in osteoarthritis — the foundational reference that citing joint-focused trials use as their literature-anchor. Industry-funded but broadly-cited and content-accurate.
Muscle
Nails
Skin
Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology: a double-blind, placebo-controlled study
Individual randomised double-blind placebo-controlled trial with objective skin biomechanical endpoints, though single-centre, female-only, and industry-supplied product with Gelita-linked co-authors.
Tier 2Oral intake of specific bioactive collagen peptides reduces skin wrinkles and increases dermal matrix synthesis
Individual randomised double-blind placebo-controlled trial with objective 3D wrinkle imaging plus suction-blister biomarker subgroup, though single-centre, female-only, and industry-supplied product with Gelita-linked co-authors.
Tier 2A collagen supplement improves skin hydration, elasticity, roughness, and density: results of a randomized, placebo-controlled, blind study
Randomised placebo-controlled single-blind trial with objective validated instrumentation (corneometry, cutometry, PRIMOS 3D, ultrasound) — well-instrumented but single-blind design and industry-funded with proprietary co-ingredient blend (not isolated collagen effect).
Tier 2An insight into the changes in skin texture and properties following dietary intervention with a nutricosmeceutical containing a blend of collagen bioactive peptides and antioxidants
Randomised double-blind placebo-controlled trial with objective skin elasticity + histological analysis in a substantial female sample — solid design but industry-funded and multi-ingredient product prevents isolating collagen effect.
Tier 1Collagen supplementation for skin health: a mechanistic systematic review
Systematic review with mechanistic focus, published in an indexed journal with academic institutional authorship — Tier 1 evidence for the mechanistic side of the skin discussion. Government-funded (Iranian university), no commercial industry ties.
Tier 2Oral Intake of Low-Molecular-Weight Collagen Peptide Improves Hydration, Elasticity, and Wrinkling in Human Skin: A Randomized, Double-Blind, Placebo-Controlled Study
Randomised, double-blind, placebo-controlled trial with instrumental skin measurements in a modest but adequate sample of the target demographic.